Back

Value and limitations of observational studies.

27 August 2018 (10:20 - 10:25)
Organised by:
Congress Presentation Part of: Oral anticoagulation in atrial fibrillation - Translating clinical trial data into daily practice Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Jan Steffel

Klinik Hirslanden, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction - Oral anticoagulation in atrial fibrillation- Translating clinical trial data into daily practice.
Professor R. De Caterina (Pisa, IT)
Presentation thumbnail
Insights from the ETNA-AF registry.
Professor J. De Groot (Amsterdam, NL)
Presentation thumbnail
Panel discussion and conclusions - Oral anticoagulation in atrial fibrillation- Translating clinical trial data into daily practice.
Professor R. De Caterina (Pisa, IT)

Access the full session

Session thumbnail
Oral anticoagulation in atrial fibrillation - Translating clinical trial data into daily practice

The Event

Event poster

ESC Congress 2018

27 August 2018 10:20 CET
You may be interested in
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Direct oral anticoagulants vs warfarin in non-valvular atrial fibrillation. Meta-analysis, includes all published trials.
27 August 2021
thumbnail
Congress Presentation
What is the burden of atrial fibrillation screening on participants and the healthcare system?
16 April 2023
thumbnail
Congress Presentation
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources